Phytosterols in physiological concentrations target multidrug resistant cancer cells

Area of Science:

• * Phytochemistry
• * Cancer Biology
• * Pharmacology

Background:

• * Phytosterols are plant-derived compounds with proposed anticancer activities.
• * The precise mechanisms underlying phytosterol anticancer effects remain largely unelucidated.
• * Investigating phytosterols' impact on cancer cells, including multidrug-resistant types, is crucial for potential therapeutic applications.

Purpose of the Study:

• * To determine if phytosterols and their derivatives influence cancer cell viability.
• * To investigate the specificity of phytosterols against multidrug-resistant cancer cells.
• * To elucidate the mechanisms of action, including cell cycle effects and P-glycoprotein (Pgp) activity.

Main Methods:

• * Cytotoxicity assays on estrogen-dependent (MCF7) and estrogen-independent (NCI/ADR-RES) cancer cell lines.
• * Cell cycle analysis using flow cytometry.
• * Assessment of P-glycoprotein (Pgp) activity.

Main Results:

• * Beta-sitosterol demonstrated cytotoxic effects on both estrogen-dependent and independent cancer cells.
• * Beta-sitosterol was more cytotoxic to MCF7 cells with basal ABCB1 expression compared to multidrug-resistant NCI/ADR-RES cells.
• * 5a,6a-epoxysitosterol increased proliferation in investigated cells and blocked MCF7 cell cycle progression in G0/G1 phase.
• * Beta-sitosterol inhibited Pgp activity, suggesting a mechanism for overcoming multidrug resistance.

Conclusions:

• * Beta-sitosterol exhibits anticancer potential through multiple mechanisms, including cytotoxicity and Pgp inhibition.
• * Phytosterols, particularly beta-sitosterol, may effectively target cancer cells with high multidrug resistance.
• * Oxyphytosterols may have proliferative effects, warranting further investigation.